138 results
8-K
EX-10.3
DYAI
Dyadic International Inc., DE
11 Mar 24
Dyadic Announces Closing of Private Placement of
8:45am
8-K
EX-10.1
DYAI
Dyadic International Inc., DE
11 Mar 24
Dyadic Announces Closing of Private Placement of
8:45am
8-K
EX-10.2
DYAI
Dyadic International Inc., DE
11 Mar 24
Dyadic Announces Closing of Private Placement of
8:45am
8-K
EX-10.4
ue260 y5rm
11 Mar 24
Dyadic Announces Closing of Private Placement of
8:45am
8-K
EX-10.1
12rb3hau
19 Sep 23
Dyadic Announces Development and License Agreement to Commercialize Animal-Free Alternative Proteins Using DapibusTM
8:30am
8-K
EX-10.1
k6ba tws1varjc9c
12 Apr 23
Dyadic Announces Expanded Licensing Agreement to Develop and Commercialize Vaccines and Biologics for African Continent
8:30am
8-K
EX-10.1
bkw0n0
23 Jan 23
Dyadic Announces Sale of Equity Interest in Alphazyme
5:22pm
8-K
EX-10.1
pcdkpe05hdpr zfw4
11 May 22
Dyadic Announces Research, License and Collaboration for the Manufacture of
9:57am
8-K
EX-10.1
5l2o4kdqze
17 Dec 21
Dyadic Announces Research, License and Collaboration Agreement with Janssen
7:10am
8-K
EX-10.1
36qgd8f6i 3vq
9 Nov 21
Dyadic Appoints Chief Business Officer to Executive Leadership Team
8:40am
8-K
EX-10.1
7k7upqpm7ga5dki3b6
11 Aug 21
Entry into a Material Definitive Agreement
8:32am
8-K
EX-10.1
dh6e6f bzkxasd
27 Jul 21
Entry into a Material Definitive Agreement
8:33am
8-K
EX-10.2
x97e31degwer5pa
27 Jul 21
Entry into a Material Definitive Agreement
8:33am
8-K
EX-10.3
062g0uf6al
27 Jul 21
Entry into a Material Definitive Agreement
8:33am